semaglutide aion The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of FDA data showed. Added 🇺🇸, A 2025 systematic review

During periods of high demand for GLP-1 medications, this initial processing step can extend to 5-7 business days

PlexusDx also offers the Precision Peptide Genetic Test to identify your unique peptide-pathway responses, which can help optimize your dosing schedule and medication selection to fit your genetics and lifestyle

Conte C, et al

Glutamate antagonists have different effects on spontaneous locomotor activity in rats

a direct, regulatory-confirmed causal link between retatrutide and vitamin B12 deficiency has not been established

However, anecdotal reports from patients and online communities suggest that some individuals do experience this symptom, particularly those achieving substantial weight loss